Admission hyperglycemia and outcome after intravenous thrombolysis: is there a difference among the stroke-subtypes?

Miedema, I., Luijckx, G-J., Brouns, R., De Keyser, J. & Uyttenboogaart, M., 15-Jul-2016, In : BMC NEUROLOGY. 16, 5 p., 104.

Research output: Contribution to journalArticleAcademicpeer-review

Background: The prognostic influence of hyperglycemia in acute stroke has been well established. While in cortical stroke there is a strong association between hyperglycemia and poor outcome, this relation is less clear in lacunar stroke. It has been suggested that this discrepancy is present among patients treated with intravenous tissue plasminogen activator (tPA), but confirmation is needed.

Methods: In two prospectively collected cohorts of patient treated with intravenous tPA for acute ischemic stroke, we investigated the effect of hyperglycemia (serum glucose level > 8 mmol/L) on functional outcome in lacunar and non-lacunar stroke. Poor functional outcome was defined as modified Rankin Scale score >= 3 at 3 months.

Results: A total of 1012 patients was included of which 162 patients (16 %) had lacunar stroke. The prevalence of hyperglycemia did not differ between stroke subtypes (22 % vs 21 %, p = 0.85). In multivariate analysis hyperglycemia was associated with poor functional outcome in non-lacunar stroke (OR 2.1, 95 % CI 1.39-3.28, p = 0.001). In patients with lacunar stroke, we did not find an association (OR 1.8, 95 % CI 0.62-4.08, p = 0.43).

Conclusion: This study confirms a difference in prognostic influence of hyperglycemia between non-lacunar and lacunar ischemic stroke.

Original languageEnglish
Article number104
Number of pages5
Publication statusPublished - 15-Jul-2016


  • Acute ischemic stroke, Hyperglycemia, Functional outcome, Tissue plasminogen activator, Stroke subtype, ACUTE ISCHEMIC-STROKE, MODERATE HYPERGLYCEMIA, BLOOD-GLUCOSE, STRESS, MANAGEMENT, INFARCTION, LACTATE, STATE, RATS

Download statistics

No data available

ID: 36006870